Review



cd4 depletion antibody  (Bio X Cell)


Bioz Verified Symbol Bio X Cell is a verified supplier
Bioz Manufacturer Symbol Bio X Cell manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 97

    Structured Review

    Bio X Cell cd4 depletion antibody
    Cd4 Depletion Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 713 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd4 depletion antibody/product/Bio X Cell
    Average 97 stars, based on 713 article reviews
    cd4 depletion antibody - by Bioz Stars, 2026-05
    97/100 stars

    Images



    Similar Products

    97
    Bio X Cell cd4 depletion antibody
    Cd4 Depletion Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 97/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd4 depletion antibody/product/Bio X Cell
    Average 97 stars, based on 1 article reviews
    cd4 depletion antibody - by Bioz Stars, 2026-05
    97/100 stars
      Buy from Supplier

    90
    Bio X Cell antibodies anti-cd4 (gk1.5) for in vivo use, depletion
    Antibodies Anti Cd4 (Gk1.5) For In Vivo Use, Depletion, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/antibodies anti-cd4 (gk1.5) for in vivo use, depletion/product/Bio X Cell
    Average 90 stars, based on 1 article reviews
    antibodies anti-cd4 (gk1.5) for in vivo use, depletion - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Bio X Cell anti-cd4 depleting antibody gk1.5
    Anti Cd4 Depleting Antibody Gk1.5, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-cd4 depleting antibody gk1.5/product/Bio X Cell
    Average 90 stars, based on 1 article reviews
    anti-cd4 depleting antibody gk1.5 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Leinco Technologies depleting antibodies specific for cd4 gk1.5
    Depleting Antibodies Specific For Cd4 Gk1.5, supplied by Leinco Technologies, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/depleting antibodies specific for cd4 gk1.5/product/Leinco Technologies
    Average 90 stars, based on 1 article reviews
    depleting antibodies specific for cd4 gk1.5 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    96
    Bio X Cell cd4 depleting antibody bioxcell
    A) Daily mice bodyweights measured from 0DPI to 5DPI. B) Lung viral titers expressed as plaque forming units per mL (PFU/mL) measured in lung homogenates at 5DPI. Limit of detection = 40 PFU/mL. C) Trivalent Influenza Vaccine (containing NC99 HA)-binding total IgG measured at 5DPI represented as Area under the curve (AUC) of the optical density at 450 nm (OD450) minus the background noise (OD650). Lung cell subpopulations at 5DPI are presented in panels D to H. D) Percentage of lung total T-cells (CD3+, gating: Live> CD45 + > CD3 + ). E) Percentage of T-cell subpopulations represented as the mean % of CD3% cells per group: <t>CD4</t> + cells (Gating: Live> CD45 + > CD3 + >CD4 + CD8 - ), CD8 + cells (Gating: Live> CD45 + > CD3 + >CD4 - CD8 + ), T regs (Gating: Live> CD45 + > CD3 + >CD4 + CD8 - >FoxP3 + ). CD3 + cells not included in any of the three subpopulations are categorized as “unassigned”. Statistical analysis: for comparisons among groups at several time points: Two-way ANOVA with Tukey’s multiple comparisons test using the OVA-Alum (IP) group as control for multiple comparisons. Color of the significance markers indicates the comparison they represent; for comparisons among groups at a specific time point: Kruskal-Wallis one-way ANOVA with Dunn’s multiple comparisons test using the OVA-Alum (IP) group as control for multiple comparisons. Significance is represented as:*p = 0.05 to 0.01, **p = 0.01 to 0.001, ***p = 0.001 to 0.0001, ***p < 0.0001.
    Cd4 Depleting Antibody Bioxcell, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd4 depleting antibody bioxcell/product/Bio X Cell
    Average 96 stars, based on 1 article reviews
    cd4 depleting antibody bioxcell - by Bioz Stars, 2026-05
    96/100 stars
      Buy from Supplier

    90
    Bio X Cell mouse cd4 depleting antibody anti-cd4
    A) Daily mice bodyweights measured from 0DPI to 5DPI. B) Lung viral titers expressed as plaque forming units per mL (PFU/mL) measured in lung homogenates at 5DPI. Limit of detection = 40 PFU/mL. C) Trivalent Influenza Vaccine (containing NC99 HA)-binding total IgG measured at 5DPI represented as Area under the curve (AUC) of the optical density at 450 nm (OD450) minus the background noise (OD650). Lung cell subpopulations at 5DPI are presented in panels D to H. D) Percentage of lung total T-cells (CD3+, gating: Live> CD45 + > CD3 + ). E) Percentage of T-cell subpopulations represented as the mean % of CD3% cells per group: <t>CD4</t> + cells (Gating: Live> CD45 + > CD3 + >CD4 + CD8 - ), CD8 + cells (Gating: Live> CD45 + > CD3 + >CD4 - CD8 + ), T regs (Gating: Live> CD45 + > CD3 + >CD4 + CD8 - >FoxP3 + ). CD3 + cells not included in any of the three subpopulations are categorized as “unassigned”. Statistical analysis: for comparisons among groups at several time points: Two-way ANOVA with Tukey’s multiple comparisons test using the OVA-Alum (IP) group as control for multiple comparisons. Color of the significance markers indicates the comparison they represent; for comparisons among groups at a specific time point: Kruskal-Wallis one-way ANOVA with Dunn’s multiple comparisons test using the OVA-Alum (IP) group as control for multiple comparisons. Significance is represented as:*p = 0.05 to 0.01, **p = 0.01 to 0.001, ***p = 0.001 to 0.0001, ***p < 0.0001.
    Mouse Cd4 Depleting Antibody Anti Cd4, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/mouse cd4 depleting antibody anti-cd4/product/Bio X Cell
    Average 90 stars, based on 1 article reviews
    mouse cd4 depleting antibody anti-cd4 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Bio X Cell anti- cd4–depleting antibody clone gk1.5
    A) Daily mice bodyweights measured from 0DPI to 5DPI. B) Lung viral titers expressed as plaque forming units per mL (PFU/mL) measured in lung homogenates at 5DPI. Limit of detection = 40 PFU/mL. C) Trivalent Influenza Vaccine (containing NC99 HA)-binding total IgG measured at 5DPI represented as Area under the curve (AUC) of the optical density at 450 nm (OD450) minus the background noise (OD650). Lung cell subpopulations at 5DPI are presented in panels D to H. D) Percentage of lung total T-cells (CD3+, gating: Live> CD45 + > CD3 + ). E) Percentage of T-cell subpopulations represented as the mean % of CD3% cells per group: <t>CD4</t> + cells (Gating: Live> CD45 + > CD3 + >CD4 + CD8 - ), CD8 + cells (Gating: Live> CD45 + > CD3 + >CD4 - CD8 + ), T regs (Gating: Live> CD45 + > CD3 + >CD4 + CD8 - >FoxP3 + ). CD3 + cells not included in any of the three subpopulations are categorized as “unassigned”. Statistical analysis: for comparisons among groups at several time points: Two-way ANOVA with Tukey’s multiple comparisons test using the OVA-Alum (IP) group as control for multiple comparisons. Color of the significance markers indicates the comparison they represent; for comparisons among groups at a specific time point: Kruskal-Wallis one-way ANOVA with Dunn’s multiple comparisons test using the OVA-Alum (IP) group as control for multiple comparisons. Significance is represented as:*p = 0.05 to 0.01, **p = 0.01 to 0.001, ***p = 0.001 to 0.0001, ***p < 0.0001.
    Anti Cd4–Depleting Antibody Clone Gk1.5, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti- cd4–depleting antibody clone gk1.5/product/Bio X Cell
    Average 90 stars, based on 1 article reviews
    anti- cd4–depleting antibody clone gk1.5 - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Bio X Cell anti-cd4 depletion antibody
    A) Daily mice bodyweights measured from 0DPI to 5DPI. B) Lung viral titers expressed as plaque forming units per mL (PFU/mL) measured in lung homogenates at 5DPI. Limit of detection = 40 PFU/mL. C) Trivalent Influenza Vaccine (containing NC99 HA)-binding total IgG measured at 5DPI represented as Area under the curve (AUC) of the optical density at 450 nm (OD450) minus the background noise (OD650). Lung cell subpopulations at 5DPI are presented in panels D to H. D) Percentage of lung total T-cells (CD3+, gating: Live> CD45 + > CD3 + ). E) Percentage of T-cell subpopulations represented as the mean % of CD3% cells per group: <t>CD4</t> + cells (Gating: Live> CD45 + > CD3 + >CD4 + CD8 - ), CD8 + cells (Gating: Live> CD45 + > CD3 + >CD4 - CD8 + ), T regs (Gating: Live> CD45 + > CD3 + >CD4 + CD8 - >FoxP3 + ). CD3 + cells not included in any of the three subpopulations are categorized as “unassigned”. Statistical analysis: for comparisons among groups at several time points: Two-way ANOVA with Tukey’s multiple comparisons test using the OVA-Alum (IP) group as control for multiple comparisons. Color of the significance markers indicates the comparison they represent; for comparisons among groups at a specific time point: Kruskal-Wallis one-way ANOVA with Dunn’s multiple comparisons test using the OVA-Alum (IP) group as control for multiple comparisons. Significance is represented as:*p = 0.05 to 0.01, **p = 0.01 to 0.001, ***p = 0.001 to 0.0001, ***p < 0.0001.
    Anti Cd4 Depletion Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/anti-cd4 depletion antibody/product/Bio X Cell
    Average 90 stars, based on 1 article reviews
    anti-cd4 depletion antibody - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    90
    Bio X Cell cd4-depleting antibody
    A) Daily mice bodyweights measured from 0DPI to 5DPI. B) Lung viral titers expressed as plaque forming units per mL (PFU/mL) measured in lung homogenates at 5DPI. Limit of detection = 40 PFU/mL. C) Trivalent Influenza Vaccine (containing NC99 HA)-binding total IgG measured at 5DPI represented as Area under the curve (AUC) of the optical density at 450 nm (OD450) minus the background noise (OD650). Lung cell subpopulations at 5DPI are presented in panels D to H. D) Percentage of lung total T-cells (CD3+, gating: Live> CD45 + > CD3 + ). E) Percentage of T-cell subpopulations represented as the mean % of CD3% cells per group: <t>CD4</t> + cells (Gating: Live> CD45 + > CD3 + >CD4 + CD8 - ), CD8 + cells (Gating: Live> CD45 + > CD3 + >CD4 - CD8 + ), T regs (Gating: Live> CD45 + > CD3 + >CD4 + CD8 - >FoxP3 + ). CD3 + cells not included in any of the three subpopulations are categorized as “unassigned”. Statistical analysis: for comparisons among groups at several time points: Two-way ANOVA with Tukey’s multiple comparisons test using the OVA-Alum (IP) group as control for multiple comparisons. Color of the significance markers indicates the comparison they represent; for comparisons among groups at a specific time point: Kruskal-Wallis one-way ANOVA with Dunn’s multiple comparisons test using the OVA-Alum (IP) group as control for multiple comparisons. Significance is represented as:*p = 0.05 to 0.01, **p = 0.01 to 0.001, ***p = 0.001 to 0.0001, ***p < 0.0001.
    Cd4 Depleting Antibody, supplied by Bio X Cell, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cd4-depleting antibody/product/Bio X Cell
    Average 90 stars, based on 1 article reviews
    cd4-depleting antibody - by Bioz Stars, 2026-05
    90/100 stars
      Buy from Supplier

    Image Search Results


    A) Daily mice bodyweights measured from 0DPI to 5DPI. B) Lung viral titers expressed as plaque forming units per mL (PFU/mL) measured in lung homogenates at 5DPI. Limit of detection = 40 PFU/mL. C) Trivalent Influenza Vaccine (containing NC99 HA)-binding total IgG measured at 5DPI represented as Area under the curve (AUC) of the optical density at 450 nm (OD450) minus the background noise (OD650). Lung cell subpopulations at 5DPI are presented in panels D to H. D) Percentage of lung total T-cells (CD3+, gating: Live> CD45 + > CD3 + ). E) Percentage of T-cell subpopulations represented as the mean % of CD3% cells per group: CD4 + cells (Gating: Live> CD45 + > CD3 + >CD4 + CD8 - ), CD8 + cells (Gating: Live> CD45 + > CD3 + >CD4 - CD8 + ), T regs (Gating: Live> CD45 + > CD3 + >CD4 + CD8 - >FoxP3 + ). CD3 + cells not included in any of the three subpopulations are categorized as “unassigned”. Statistical analysis: for comparisons among groups at several time points: Two-way ANOVA with Tukey’s multiple comparisons test using the OVA-Alum (IP) group as control for multiple comparisons. Color of the significance markers indicates the comparison they represent; for comparisons among groups at a specific time point: Kruskal-Wallis one-way ANOVA with Dunn’s multiple comparisons test using the OVA-Alum (IP) group as control for multiple comparisons. Significance is represented as:*p = 0.05 to 0.01, **p = 0.01 to 0.001, ***p = 0.001 to 0.0001, ***p < 0.0001.

    Journal: bioRxiv

    Article Title: A combination TLR7/8 and RIG-I agonist adjuvant reverts asthmatic allergic sensitization and prevents aggravated influenza infection in OVA-sensitized mice

    doi: 10.1101/2025.06.23.659362

    Figure Lengend Snippet: A) Daily mice bodyweights measured from 0DPI to 5DPI. B) Lung viral titers expressed as plaque forming units per mL (PFU/mL) measured in lung homogenates at 5DPI. Limit of detection = 40 PFU/mL. C) Trivalent Influenza Vaccine (containing NC99 HA)-binding total IgG measured at 5DPI represented as Area under the curve (AUC) of the optical density at 450 nm (OD450) minus the background noise (OD650). Lung cell subpopulations at 5DPI are presented in panels D to H. D) Percentage of lung total T-cells (CD3+, gating: Live> CD45 + > CD3 + ). E) Percentage of T-cell subpopulations represented as the mean % of CD3% cells per group: CD4 + cells (Gating: Live> CD45 + > CD3 + >CD4 + CD8 - ), CD8 + cells (Gating: Live> CD45 + > CD3 + >CD4 - CD8 + ), T regs (Gating: Live> CD45 + > CD3 + >CD4 + CD8 - >FoxP3 + ). CD3 + cells not included in any of the three subpopulations are categorized as “unassigned”. Statistical analysis: for comparisons among groups at several time points: Two-way ANOVA with Tukey’s multiple comparisons test using the OVA-Alum (IP) group as control for multiple comparisons. Color of the significance markers indicates the comparison they represent; for comparisons among groups at a specific time point: Kruskal-Wallis one-way ANOVA with Dunn’s multiple comparisons test using the OVA-Alum (IP) group as control for multiple comparisons. Significance is represented as:*p = 0.05 to 0.01, **p = 0.01 to 0.001, ***p = 0.001 to 0.0001, ***p < 0.0001.

    Article Snippet: For the depletion of the different T-cell subpopulations, mice were injected intraperitoneally with either CD4 depleting antibody BioXCell #BP0003-1 (clone YTS 177) with a dosing of 500 μg in 100 μL PBS, CD8 depleting antibody BioXCell #BE0223 (clone 53-5.8) with a dosing 250 μg in 100μL PBS or a combination of both, 72 and 24 hr prior to the first OVA challenge.

    Techniques: Binding Assay, Control, Comparison